Hydrochloric Acid → (5S)-2,2-dimethyl-5-((1S)-3-methyl-1-{[4-(3-phenyl-1,2,4-thiadiazol-5-yl)-1-piperazinyl]carbonyl}butyl)-1,3-dioxolan-4-one

HRID 1677780ノート

反応式

HRID 1677780 の反応式
[CH3:1][C:2]1([CH3:27])[O:6][C@@H:5]([C@H:7]([CH2:22][CH:23]([CH3:25])[CH3:24])[C:8]([O:10]C2C(F)=C(F)C(F)=C(F)C=2F)=O)[C:4](=[O:26])[O:3]1.ONC(=O)[C@@H](O)[C@@H](C(N1CCN(C2C=CC=CN=2)CC1)=O)CC(C)C.[C:53]1([C:59]2[N:63]=[C:62]([N:64]3[CH2:69][CH2:68][NH:67][CH2:66][CH2:65]3)[S:61][N:60]=2)[CH:58]=[CH:57][CH:56]=[CH:55][CH:54]=1.Cl>CN(C=O)C>[CH3:27][C:2]1([CH3:1])[O:3][C:4](=[O:26])[C@H:5]([C@@H:7]([C:8]([N:67]2[CH2:68][CH2:69][N:64]([C:62]3[S:61][N:60]=[C:59]([C:53]4[CH:58]=[CH:57][CH:56]=[CH:55][CH:54]=4)[N:63]=3)[CH2:65][CH2:66]2)=[O:10])[CH2:22][CH:23]([CH3:24])[CH3:25])[O:6]1

参加物

6

反応物 4

HCID 313Hydrochloric AcidHCID 27777601-(3-Phenyl-(1,2,4)thiadiazol-5-yl)-piperazineHCID 11653205HCID 11653205、化合物2 回HCID 86617975HCID 86617975、化合物

生成物 1

HCID 58487953(5S)-2,2-dimethyl-5-((1S)-3-methyl-1-{[4-(3-phenyl-1,2,4-thiadiazol-5-yl)-1-piperazinyl]carbonyl}butyl)-1,3-dioxolan-4-one収率 5.8%

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

実験手順

To a solution of a 55/45 diastereoisomeric mixture of pentafluorophenyl (2S)-2-[(4S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl]-4-methylpentanoate and pentafluorophenyl (2R)-2-[(4S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl]-4-methylpentanoate (Intermediate 1; 150.0 mg; 0.38 mmol; 1.0 eq.) in DMF (1.5 mL) was added 3-phenyl-5-piperazino-1,2,4-thiadiazole (93.2 mg; 0.38 mmol; 1.0 eq.) and the resulting reaction mixture was stirred at RT for 14 h. An aqueous solution of HCl (1N) was added and the resulting mixture was extracted with EtOAc, dried over MgSO4, filtered and evaporated to give an oil. This residue was taken up in CD3OD. The precipitate was filtered off and the mother liquids were evaporated and the resulting residue was then purified by chromatography (SiO2, gradient from 2/1 to 1/1 c-hex/EtOAc in about 30 min) to give the title product as a colorless oil (10 mg; 5.8%). M+(ESI): 459.0. HPLC (Condition A): Rt: 4.5 min (HPLC purity: 98.5%).

後処理

  1. customthe resulting reaction mixture
  2. extractionthe resulting mixture was extracted with EtOAc
  3. dry with materialdried over MgSO4
  4. filtrationfiltered
  5. customevaporated
  6. customto give an oil
  7. filtrationThe precipitate was filtered off
  8. customthe mother liquids were evaporated
  9. customthe resulting residue was then purified by chromatography (SiO2, gradient from 2/1 to 1/1 c-hex/EtOAc in about 30 min)

出典と根拠

ORDレコード
ord-9d85992bf352491db9ce8dc24f70337e
出典データセット
uspto-grants-2011_08
特許番号
US08008302B2

反応ノート

読み込み中…